Apellis Pharmaceuticals Inc. (APLS) Climbed 7.42% or 1.3 To Price $18.83 On Thursday

Apellis Pharmaceuticals Inc. (APLS) climbed 7.42% or 1.3 to $18.83. It is approximately 294760 shares traded, which is 116.32% compare to the average total volume 253409. The market cap of APLS is $1.06 billion. The year to date change is -8.22%. The 52 week price range is from $12.45 to $32.0. Price of APLS have changed -4.00% during last week. It have changed -6.46% over last month, -26.38% over last 3 months, 17.26% over last 6 months and 24.95% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for APLS is 19.76. It is 4.94% above current price. The 200-day Moving Averages for APLS is 19.69. It is 4.57% above current price. The 52-week High is 32.0. It is 69.94% from the current price. The 52-week Low is 12.45. It is -33.88% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of APLS is 10.45 on 2018-07-31. Short % to float is 5.56%. There are some statistics of APLS. It is has market cap $1.06 billion. The share outstanding is 56.18 million. The average volume is 253409. The percent of top 15 Institution holding is 51.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of APLS is -66.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of APLS is -52.49%.


Share this post